Search

everythinglearnresearchcommunity

for

Search:↓

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

Inhibiting TYK2 can restore hair growth in alopecia areata.

A man had two rare autoimmune diseases that might be connected.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

Trichohyalin in hair can trigger immune attacks in alopecia areata.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

FGF18 helps hair follicles resist radiation by stopping hair growth cycles.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.